Multi-Chem (AWZ) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
3 Nov, 2026Executive summary
FY2025 revenue was $653.9M, down 4.4% YoY; PBT fell 15.1% to $33.0M and net profit fell 14.2% to $26.4M.
2H2025 revenue rose 3.4% YoY to $352.9M, while PBT declined to $15.9M from $18.0M and PAT to $12.2M from $14.4M.
Financial highlights
FY2025 gross profit was $89.6M versus $97.5M; reported gross margin was 13.7% versus 14.3%.
FY2025 EBITA was $38.1M versus $42.3M; PBT was $33.0M versus $38.8M; net profit was $26.4M versus $30.8M.
Basic and diluted EPS was 29.35 cents versus 34.21 cents; net asset value per share was 168.98 cents versus 171.16 cents.
2H2025 revenue increased 17.2% QoQ to $352.9M from $301.0M in 1H2025; PAT decreased 14.1% QoQ to $12.2M from $14.2M.
Outlook and guidance
IT distribution is expected to remain the primary business; continued cybersecurity demand and security's role in IT infrastructure underpin the outlook.
Priorities include focusing on best-of-breed products, selective product range management, regional expansion, M.Tech brand promotion and closer work with key partners.
Regional offices across 24 cities in 13 countries are expected to contribute positively in 2026; mature operations are expected to contribute more.
Latest events from Multi-Chem
- IT-led growth lifted H1 net profit 18%; interim dividend declared at 8.80 cents per share.AWZ
H1 2023 - IT-led growth lifted FY2024 profit, while macro and currency risks persist.AWZ
H2 2024 - IT-led growth lifted H1 profit 44%, while working-capital needs weighed on cash flow.AWZ
H1 2024 - IT-led growth lifted H1 revenue 15%, while global uncertainty clouds the outlook.AWZ
H1 2026 - IT-led growth lifted profit, while a qualified audit opinion raises a significant governance concern.AWZ
H2 2023 - Lower IT sales and FX headwinds cut H1 revenue 12% and net income 13%.AWZ
H1 2025